Biomarkers for severe eosinophilic asthma.

Biomarkers for severe eosinophilic asthma.

The last decade has seen the approval of several new biologics for the treatment of severe asthma-targeting specific endotypes and phenotypes. This review will examine how evidence generated from the mepolizumab clinical development program showed that blood eosinophil counts, rather than sputum or...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Yancey, S, Keene, O, Albers, F, Ortega, H, Bates, S, Bleecker, E, Pavord, I
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	Elsevier 2017

Ижил төстэй зүйлс

Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma
-н: Yancey, S, зэрэг
Хэвлэсэн: (2016)

Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.
-н: Ortega, H, зэрэг
Хэвлэсэн: (2016)

Evaluation of potential continuation rules for mepolizumab treatment of severe eosinophilic asthma.
-н: Gunsoy, N, зэрэг
Хэвлэсэн: (2017)

Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma
-н: Shrimanker, R, зэрэг
Хэвлэсэн: (2018)

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
-н: Pavord, I, зэрэг
Хэвлэсэн: (2012)

Mepolizumab treatment in patients with severe eosinophilic asthma.
-н: Ortega, H, зэрэг
Хэвлэсэн: (2014)

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
-н: Bel, E, зэрэг
Хэвлэсэн: (2014)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
-н: Steven W. Yancey, зэрэг
Хэвлэсэн: (2019-09-01)

Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide and their combination in severe asthma: a post-hoc analysis
-н: Shrimanker, R, зэрэг
Хэвлэсэн: (2019)

Glucocorticoids and mepolizumab in eosinophilic asthma.
-н: Bel, E, зэрэг
Хэвлэсэн: (2014)

Mepolizumab, quality of life, and severe eosinophilic asthma.
-н: Pavord, I
Хэвлэсэн: (2017)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
-н: Howell, I, зэрэг
Хэвлэсэн: (2024)

Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes
-н: Prazma CM, зэрэг
Хэвлэсэн: (2021-06-01)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
-н: Imran Howell, зэрэг
Хэвлэсэн: (2024-07-01)

Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma
-н: Terufumi Shimoda, зэрэг
Хэвлэсэн: (2017-07-01)

Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis
-н: Charlene M. Prazma, зэрэг
Хэвлэсэн: (2019-05-01)

Eosinophils in asthma and airway hyperresponsiveness.
-н: Brightling, C, зэрэг
Хэвлэсэн: (2004)

Feno and blood eosinophils as biomarkers in predicting asthma exacerbations
-н: Rastogi, S, зэрэг
Хэвлэсэн: (2017)

Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
-н: Kulkarni, N, зэрэг
Хэвлэсэн: (2010)

Non-eosinophilic asthma and the innate immune response.
-н: Pavord, I
Хэвлэсэн: (2007)

Severe eosinophilic asthma: a roadmap to consensus.
-н: Buhl, R, зэрэг
Хэвлэсэн: (2017)

Mepolizumab in refractory eosinophilic asthma.
-н: Pavord, I, зэрэг
Хэвлэсэн: (2010)

IL-5 antagonism reverses priming and activation of eosinophils in severe eosinophilic asthma
-н: Luo, J, зэрэг
Хэвлэсэн: (2024)

A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels
-н: Haughney, J, зэрэг
Хэвлэсэн: (2017)

Efficacy and safety of mepolizumab in Korean patients with severe eosinophilic asthma from the DREAM and MENSA studies
-н: Mi-Kyeong Kim, зэрэг
Хэвлэсэн: (2021-03-01)

Eosinophilic bioactivities in severe asthma
-н: Tara F. Carr, зэрэг
Хэвлэсэн: (2016-01-01)

Non-eosinophilic corticosteroid unresponsive asthma.
-н: Pavord, I, зэрэг
Хэвлэсэн: (1999)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
-н: Shrimanker, R, зэрэг
Хэвлэсэн: (2017)

Controversies in allergy: should severe asthma with eosinophilic phenotype always be treated with anti-IL-5 therapies
-н: Pavord, I, зэрэг
Хэвлэсэн: (2019)

Eosinophils in asthma and other allergic diseases.
-н: Wardlaw, A, зэрэг
Хэвлэсэн: (2000)

The significance of eosinophilic airway inflammation in asthma
-н: Pavord, I, зэрэг
Хэвлэсэн: (2002)

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
-н: Brightling, C, зэрэг
Хэвлэсэн: (2003)

Asthma heterogeneity and severity
-н: Tara F. Carr, зэрэг
Хэвлэсэн: (2016-01-01)

Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
-н: Pavord, I, зэрэг
Хэвлэсэн: (2017)

Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA
-н: Frank C. Albers, зэрэг
Хэвлэсэн: (2019-07-01)

Eosinophils in COPD: just another biomarker?
-н: Bafadhel, M, зэрэг
Хэвлэсэн: (2017)

Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants.
-н: Anees, W, зэрэг
Хэвлэсэн: (2002)

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
-н: Moran, AM, зэрэг
Хэвлэсэн: (2020)

Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment
-н: Lavoie, G, зэрэг
Хэвлэсэн: (2024)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
-н: Shrimanker, R, зэрэг
Хэвлэсэн: (2017)